Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

60.20
BATS BZX Real-Time Price
As of 2:10pm ET
 +3.01 / +5.26%
Today’s Change
46.52
Today|||52-Week Range
133.40
-46.34%
Year-to-Date

Today’s Trading

Previous close57.19
Today’s open58.34
Day’s range58.24 - 61.41
Volume33,076
Average volume (3 months)673,764
Market cap$2.2B
Dividend yield--
Data as of 2:10pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)-76.00%
Earnings growth (this year)-46.63%
Earnings growth (next 5 years)+38.29%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.19

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+0.40+1.30%
GLPGGalapagos NV-0.05-0.09%
IRWDIronwood Pharmaceuti...+0.20+1.41%
GWPHGW Pharmaceuticals P...-0.25-0.27%
Data as of 2:12pm ET, 07/27/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$1.44
Annual revenue (last year)$0.00
Annual profit (last year)-$145.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Emil D. Kakkis
CFO, Senior VP &
Head-Investor Relations
Shalini Sharp
Corporate headquarters
Novato, California

Forecasts

Partner Offers

Search for Jobs